Orally-delivered insulin-peptide nanocomplexes enhance transcytosis from cellular depots and improve diabetic blood glucose control. (2023)
Attributed to:
Acellular Approaches for Therapeutic Delivery: UK Regenerative Medicine Platform Hub Application
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jconrel.2023.06.006
PubMed Identifier: 37315695
Publication URI: http://europepmc.org/abstract/MED/37315695
Type: Journal Article/Review
Volume: 360
Parent Publication: Journal of controlled release : official journal of the Controlled Release Society
ISSN: 0168-3659